CDD Cares: Cervical Cancer Screening Programs
Early Detection Initiative
Globally, cervical cancer is the second most common malignancy in women and the third most common cause of death (due to malignancy) in women. Early detection/confirmation of disease/infection grants the best possibility for survival, improves overall treatment outcomes, and lowers long-term healthcare costs for all involved parties.
For this reason, in January 2012, the Center for Disease Detection (CDD) committed corporate social responsibility funding to an Early Detection Initiative. To support this initiative, CDD formed private partnerships with organizations such as Roche, Hologic, and IncellDx, and joined multi-lateral initiatives such as the Pan American Forum for Action on NCDs.
Human Papillomavirus (HPV) Education and Outreach Program
CDD has been working with various non-profit and non-governmental organizations to support their cervical cancer screening outreach efforts. In particular, HPV Education and Outreach programs which target countries that have not yet been able to reach at least 70% of their target screening population, with specific focus on countries without organized screening programs. The overall goal of the program is to educate patients on the potential benefits of cervical cancer screening, make them aware of the option for HPV testing, and increase patient participation in overall screening activities at the nationally recommended screening interval.
Non-profit/Non-governmental organizations interested in establishing a similar program in their service area can respond to the Request for Applications (RFA).
Partnership with Local (Representative) Laboratories
Non-profit/Non-governmental organizations interested in establishing a similar program in their service area can respond to the RFA.
Laboratories who would like additional information on this program should email: email@example.com